Safety evidence
Adverse events, serious adverse events, and safety signals: terms that are not interchangeable
An adverse event is an unfavorable occurrence after participation and does not by itself establish causality. Seriousness is defined by outcomes such as hospitalization or threat to life, while severity describes intensity and a safety signal is a pattern requiring evaluation.
Educational content only. Not medical advice.
Occurrence is not the same as causation
An adverse event is an unfavorable health change that occurs during or after a study-defined period, whether or not the intervention caused it. Investigators and sponsors assess timing, alternative causes, dechallenge or rechallenge information, biological plausibility, and accumulated evidence when considering relatedness. A table of events should not be relabeled as a table of proven side effects.
Seriousness and severity describe different dimensions
Serious adverse events meet outcome-based criteria such as death, life-threatening risk, hospitalization, significant disability, congenital anomaly, or another medically important event. Severity describes intensity, often as mild, moderate, or severe. A severe headache may not meet seriousness criteria, while a medically serious event may begin with modest symptoms.
Expectedness and suspected reactions affect reporting
Expectedness asks whether the event is consistent with current reference safety information. A suspected adverse reaction has a reasonable possibility of causal relationship. Serious, unexpected suspected reactions can trigger expedited reporting, but individual reports are only one layer of surveillance; aggregate patterns, exposure, background rates, and data quality matter.
Safety signals require denominators and context
A signal is information suggesting a new potential association or a changed understanding that deserves investigation. Read event counts with numbers exposed, follow-up time, ascertainment method, comparison group, withdrawals, and competing events. Absence of a signal in a small or short study does not prove safety, and a numerical imbalance alone does not prove causation.
Evidence limits
- Small or short trials cannot reliably detect rare, delayed, or exposure-dependent harms.
- Causality assessment can remain uncertain even when an event is serious or unexpected.
- Reporting systems and coding conventions can differ across studies and development stages.
Sources and further reading
These sources ground the definitions and evidence boundaries on this page. A citation is a route for verification, not an endorsement of a product or personal use.
U.S. Food and Drug Administration / ICH
E2A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
Official definitions separating adverse events, serious events, expectedness, and suspected reactions.
Open sourceU.S. Food and Drug Administration
IND Application Reporting: IND Safety Reports
Current official context for sponsor safety surveillance and reporting responsibilities.
Open sourceClinicalTrials.gov, U.S. National Library of Medicine
Glossary Terms
Official definitions for trial phases, outcomes, masking, eligibility, adverse events, and study status.
Open sourceCommon questions
Does adverse event mean the study intervention caused it?
No. The term begins with temporal occurrence; causality requires separate assessment.
Is severe the same as serious?
No. Severe describes intensity; serious is based on defined outcomes and medical importance.
Does zero serious events prove safety?
No. Sample size, duration, exposure, surveillance, and background risk determine what could have been detected.
Continue with context
Keep building your evidence-reading skills
Explore the public PeptideSchool research library for more source-backed methods, glossaries, and evidence maps.